Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said in a statement to stock exchanges.

No comments:

Post a Comment